Securities code: 300398 securities abbreviation: Phichem Corporation(300398) Announcement No.: 2022-004
Bond Code: 123078 bond abbreviation: FeiKai convertible bond
Annual performance forecast for 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate, complete and free from falsehood
Records, misleading statements or material omissions.
1、 Expected performance of the current period
1. Performance forecast period: January 1, 2021 to December 31, 2021
2. Expected performance: □ loss □ turning loss into profit √ rising in the same direction □ falling in the same direction □ basically flat
The reporting period of the project (January December 2021) is the same period as that of the previous year (January December 2020)
Attributable to listed companies increased by 50% – 75% compared with the same period of last year
Net profit of shareholders: 229.8329 million yuan
Profit: 344.7494 million yuan – 402.2076 million yuan
2、 Performance forecast and pre audit
This performance forecast has not been audited by certified public accountants.
3、 Explanation of performance change reasons
During the reporting period, the epidemic situation in China was effectively controlled, and the downstream enterprises of the company gradually resumed work and production, making the company
The market demand for main products has increased, and the sales volume has increased significantly. Among them, the field of screen display is in the company’s LCD and
While the sales volume of positive photoresist is growing rapidly, the new product negative photoresist will begin to scale in the second half of 2021
Mold sales, so that the operating revenue of screen display materials increases rapidly; Secondly, due to the downstream of semiconductor materials
With the increase of demand, the company’s semiconductor material revenue also continued to maintain a good growth rate; In addition, the company UV
The shipment of cured optical fiber coating materials resumed growth, and UV cured material products were used in automobiles, functional films, etc
The new business areas have been widely applied, bringing certain growth to the company’s operating revenue in the reporting period; Moreover, due to the strong demand of downstream customers and the surge in sales of some products of pharmaceutical intermediates, the operating revenue of pharmaceutical intermediates increased significantly during the reporting period, especially in the second half of 2021. Finally, during the reporting period, in order to implement the annual business plan of the board of directors, the company actively strengthened internal control, steadily promoted various projects of the company, accelerated market development, and ensured the increase of the company’s operating revenue and operating profit during the reporting period.
It is estimated that the impact of non recurring profit and loss on net profit of the company in the reporting period is about 38.5206 million yuan, and the impact of non recurring profit and loss on net profit in the same period of last year is 48.1766 million yuan. 4、 Other relevant instructions
1. This performance forecast is the result of preliminary calculation by the company’s financial department and has not been pre audited by the audit institution. 2. The specific data of 2021 annual performance will be disclosed in detail in the company’s 2021 annual report. Please make careful decisions and pay attention to investment risks.
It is hereby announced.
Phichem Corporation(300398) board of directors January 9, 2022
